Cannabinoids Meet Gum, AXIM Joins with KISS

Cannabinoids Meet Gum, AXIM Joins with KISS

By: Dylan Sikes – News

Tuesday, July 9, 2019

Some cannabis concerns are more imaginative than others.

New York-based AXIM Biotechnologies, Inc. (OTC:AXIM), a world leader in cannabinoid research and product development proved it Tuesday by telling investors it’s signed a multi-term agreement with Colorado-based gum developer KISS Industries, LLC, makers of CONFADENT Sugar-Free Chewing Gum. 

The agreement grants KISS Industries a non-exclusive license to formulate and sell products that fall within AXIM’s patent on chewing gum containing cannabinoids and grants AXIM the ability to acquire 10% of KISS Industries.

Said CEO John Huemoeller, “As we focus on building revenue from our growing nutraceutical division, we understand the importance of maintaining AXIM’s reputation for providing high-quality full-spectrum hemp cannabidiol (CBD) products. KISS Industries will increase our capacity and sales channels through its distribution.”

Shares in AXIM took on five cents, or 6.3%, to 86 cents, on volume of 49,000 shares.

Copyright © 2019 All rights reserved. Republication or redistribution of's content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon

Other Penny Stock Movers

Bee Revels in Patent Nod
Stocks Soar for Cannabis Companies
Cannabis Concern Assures Investors During COVID Crisis
Most Popular
FREE Newsletter

Back to Top